Lee et al., 2022)
Tirzepatide interacts with gut receptors that influence motility, secretion, and inflammation
2023a, Neumann et al
Check whether the COA includes batch numbers, testing dates, analytical method details (HPLC column specifications, mobile phase composition), and the identity of the testing laboratory
Falls and accidents : Particularly relevant for older patients, where the risk of falls and fractures is already elevated
In developing regions, this financial barrier is even more pronounced, slowing market penetration despite growing obesity prevalence While efforts are underway to improve affordabilityincluding the introduction of generic formulations and price negotiations in certain marketsthe perception of GLP-1 therapies as premium, high-cost treatments can deter both patients and providers from widespread adoption Overcoming these challenges through the development of cost-effective alternatives, enhanced insurance support, and patient assistance programs will be vital for ensuring sustained and inclusive market growth in the GLP-1 receptor agonists obesity drugs market GLP-1 Receptor Agonists Obesity Drugs Market Scope The market is segmented on the basis of drug type, route of administration, application, and distribution channel